Summary
Effective for dates of service beginning January 1, 2027, Harvard Pilgrim Health Care Commercial and Tufts Health Direct products will require modifier 33 in the first modifier field, plus one listed cervical diagnosis code in the primary position, on specified biopsy, colposcopy, dual stain, and pathology codes so those services are considered preventive under the cervical cancer screening benefit. The practice should update charge entry and claim edits to capture the modifier and diagnosis sequence for these plans before that date.
Get alerts when payers change rules like this one
We check Harvard Pilgrim Health Care and other payers every day and email you when a change matches your specialty and state.